Until recently. In 2024, femtech companies raised $1.19 billion across 111 deals, a slightly decrease from the 120 deals in 2023, but an increase from the $1.14 billion raised the year prior. Of course, neither could match the high of the pandemic, which was 177 deals across $1.31 billion in 2021.
The average deal size for women’s health companies also rose in 2024 to $10.71 million, up from the previous high of $10.36 million in 2023.
Here are the top 25 funding rounds in the femtech space since 2023:
Flo Health
Description: “Flo Health develops a women’s health app that provides access to cycle tracking, health insights, and a private community”
Round size: $200 million
Investors: General Atlantic
Date: July 2004
Total funding: $278.5 million
Description: “Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. We envision a world where all women and their babies have access to safe and effective therapies for treating life threatening complications of pregnancy, and those solutions must be evidence-based and affordable.”
Round size: $75 million; $36.1 million
Investors: NEA, Atlas Venture, GV, F-Prime Capital, Lilly Asia Ventures, Longview Healthcare Ventures
Date: January 2024; May 2023
Total funding: $111.1 million
Description: “Freya is a clinical-stage company taking an innovative approach to women’s health, with microbial immunotherapies aimed at relieving the chronic inflammation underlying a range of reproductive system diseases uniquely afflicting women.”
Round size: $38 million; $11.8 million
Investors: Export and Investment Fund, Bill & Melinda Gates Foundation
Date: December 2023; November 2024
Total funding: $49.8 million
Description: “Women’s healthcare that puts you in the driver’s seat. In-person and virtual care to treat the whole you – mental, physical, and social – no matter what stage of life you’re in.”
Round size: $34 million
Investors: Norwest Venture Partners. Existing investors .406 Ventures, LRVHealth, AlleyCorp
Date: October 2023
Total funding: $45 million
Description: “Gameto is a female-led biotech company developing treatment solutions to improve women’s reproductive health throughout their lives: from egg freezing, infertility, and diseases of the reproductive years to menopause and conditions that occur afterward.”
Round size: $33 million;
Investors: Two Sigma Ventures, RA Capital, Insight Partners, Future Ventures, BOLD Capital Partners, Ingeborg Investments, Stacey Bendet Eisner, Chelsea Hirschhorn, Anne Wojcicki, Bob Nelsen, Arcadia Investment Partners, Overwater Ventures, Plum Alley, Lux Capital, FJ Labs, SALT Fund, Myelin VC, TA Ventures, Jack Abraham of Atomic, YES VC, Dan Rose
Date: May 2024
Total funding: $73 million
Description: “Oula delivers better maternity care, offering comprehensive support before, during, and after pregnancy. We listen, respect your preferences, and make decisions together, leading to better outcomes for both you and your baby”
Round size: $28 million; $19.1 million
Investors: Revolution Ventures, Maverick Ventures, GV, the Female Founders Fund, 8VC, Alumni Ventures, Great Oaks, Metrodora, Collaborative Fund, January Ventures, Rock Health, Black Jays, Kate Ryder, Tom Lee, Jonathan Bush
Date: February 2024; January 2023
Total funding: $50.3 million
Description: “Novocuff, Inc. is a medical device company dedicated to improving outcomes for pregnancies affected by preterm premature rupture of membranes (PPROM) or cervical shortening”
Round size: $26 million
Investors: AXA IM Alts, Laerdal Million Lives Fund, Laborie, RH Capital, Avestria Ventures, March of Dimes
Date: July 2024
Total funding: $28 million
Description: “Delfina Care is an integrated pregnancy platform delivering personalized care based on deep insights into each member’s needs. Care teams can automate routine tasks and activate proactive care plans. Pregnant members receive a fun app with equitable access to education, continuous doula support,
telehealth services, and at-home monitoring”
Round size: $17 million
Investors: US Venture Partners, ARTIS Ventures, Mayo Clinic, Tokio Marine Future Fund, Story Ventures, SemperVirens, Bread and Butter Ventures, Boutique Ventures, Metrodora Ventures
Date: January 2025
Total funding: $22.3 million
Description: “A ground breaking AI-enabled early detection platform focused on women’s health”
Round size: $17 million
Investors: Good Growth Capital, RH Capital, Y Combinator, Astia, Adaptive Capital Partners, Gore Range Capital, LongeVC, The Helm, VU Venture Partners, FemHealth Ventures, CANCER FUND, Labcorp Venture Fund
Date: October 2023
Total funding: $24.5 million
Description: “We build brands that make a difference in the lives of women and those they love”
Round size: $15 million
Investors: FCA Venture Partners, MAP Investco, Define Ventures, Link Ventures, Redesign Health
Date: May 2023
Total funding: $130 million
Description: “Gaia combines reproductive health data with financial technology to make IVF treatments more accessible, affordable, and personal”
Round size: $14 million
Investors: Valar Ventures
Date: January 2025
Total funding: $37 million
Description: “Needed is a pregnancy nutrition and education company that provides perinatal nutrition system supplements for women”
Round size: $14 million
Investors: The Craftory, Seae Ventures
Date: November 2023
Total funding: $26.4 million
Description: “Rapidly integrate and deploy high quality, low cost, remote patient centered care to improve the health of mom and baby”
Round size: $12.9 million
Investors: SOSV, HAX
Date: September 2024
Total funding: $29 million
Description: “Mitigate more risks with the world’s most advanced whole genome screening for embryos”
Round size: $12 million
Investors: Prometheus Fund, Refactor Capital, Anne Wojcicki, Dylan Field, Fidji Simo, Brian Armstrong, Starbloom Capital, Pebblebed, Day One Ventures, Conviction Capital
Date: December 2023
Total funding: $16.5 million
Description: “Elvie is a femtech company that specializes in developing innovative technology to support women’s health and wellness”
Round size: $11.19
Investors: BlackRock, Octopus Ventures
Date: April 2024
Total funding: $188.9 million
Description: “Gynoveda is a FemTech company that combines technology and ayurveda to promote healthy menstrual cycles”
Round size: $10 million
Investors: India Alternatives Fund, Wipro Enterprises, RPG Ventures, Dharampal Satyapal Ltd, Alteria Capital
Date: March 2023
Total funding: $10 million
Description: “Our mission is to introduce an innovative, high-quality intrauterine drug-delivery technology to improve and impact women’s health and quality of life”
Round size: $10 million
Investors: RH Capital, Features Capital, Astia Angels, Exerte Partners
Date: June 2024
Total funding: $29.5 million
Description: “Heranova is developing innovative diagnostics and treatments designed to improve women’s
health and address reproductive challenges”
Round size: $10 million
Investors: Sinovation Ventures, Pivotal bioVenture Partners
Date: March 2023
Total funding: $13.5 million
Description: “Jane is the only longitudinal molecular study of women’s menstruation on the planet”
Round size: $7 million
Investors: Undisclosed
Date: October 2023
Total funding: $19.8 million
Description: “At Twig Fertility, we believe that medicine and manner must be in balance to achieve a better experience for one and all. For us, mental and emotional health are key elements to achieving success in building your family. We celebrate that everyone is different and so is their path to realizing their goals”
Round size: $5.9 million
Investors: Rhino Ventures
Date: June 2023
Total funding: $6.2 million
Description: “Women-first, women-centered comprehensive care to empower you to take charge of your health”
Round size: $5.5 million
Investors: Integra Partners, Kaya Founders, KSR Ventures, Ava Zobel Pessina, Pawikan Capital Group, Tenco Capital, Dr. Frans Beltran, Micaela Beltran.
Date: July 2024
Total funding: $5.5 million
Description: “FamilyWell equips OB clinics with billable, tech-enabled, perinatal mental health services covered by insurance”
Round size: $4.3 million
Investors: Mother Ventures, GreyMatter, .406 Ventures
Date: February 2024
Total funding: $5.3 million
Description: “Providing virtual care and support for parents across pregnancy and postpartum, SimpliFed’s mOS or Maternal Health Operating System is designed to create a seamless experience for both patients and providers”
Round size: $4 million
Investors: Morningside, The Artemis Fund, Cultivation Capital, and American Heart Association Social Impact Funds, The Venture Collective, Empire State Development, Waterline Ventures
Date: February 2025
Total funding: $10.5 million
Description: “Designed for independent women’s health practices including OB/GYNs, Midwives, and Practice Managers to support seamless clinical and administrative operations”
Round size: $4 million
Investors: Undisclosed
Date: October 2024
Total funding: $4 million
Description: “We have a big mission at Luna Daily to connect women to each other and their entire bodies. I believe it starts with education that drives understanding, amplified by conversations between women of all ages and stages, together”
Round size: £3 million
Investors: Redrice Ventures, Juice, Joyance Partners, Unilever Ventures
Date: March 2023
Total funding: £4.7m million
(Image source: pmwcintl.com)